Acute Myeloid Leukemia: What to Know, What to Do
Learn what causes acute myeloid leukemia (AML), who's at risk of developing AML and treatment options.
Webinar
You are here
Celebrating My Second Re-Birthday
A transplant survivor shares tips for preparing for transplant, making the hospitalization meaningful and surviving and thriving afterward.
Transplant or CAR T-cell Therapy for Lymphoma? How to Make the Choice
A transplant using the patient's own stem cells (an autologous stem cell transplant) or CAR T-cell therapy are treatment options for patients with certain types of lymphoma.
Being a Caregiver: CAR T-Cell Therapy
This is a recording of the webinar, Being a Caregiver: CAR T-Cell Therapy, that aired on February 1, 2023.
COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know
This is a recording of the webinar, COVID-19 and Monkeypox: What Transplant and CAR T-cell Recipients Need to Know, that aired November 16, 2022.
Major Treatment Decisions for Patients with Acute Myeloid Leukemia (AML)
Acute myeloid leukemia is a diagnosis that affects mainly older adults. Treatment options depend on the type of AML a patient has, age, prior treatment and general health. Learn the details on how recommendations for treatment are determined.
Managing Vaginal Graft-versus-Host Disease (GVHD)
Graft-versus-host disease (GVHD) is a frequent complication after a stem cell transplant using donor cells. GVHD can affect many parts of the body including the genitals.
Prevención y Tratamiento de la Enfermedad Injerto Contra Huésped (EICH)
Prevention and Treatment of Graft-versus-Host Disease (GVHD) - Video in Spanish
CAR T-cells in Non-Hodgkin Lymphoma, A Hopeful Option
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
COVID-19: Precautions, Vaccines and Treatments for Transplant Recipients
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
Acute Myeloid Leukemia: Increasing Complexity and Increasing Treatment Opportunities
Learn about the different types of acute myeloid leukemia (AML), how it is treated, and when transplant is the best option.
CAR T-cell Therapy for Patients with Multiple Myeloma
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
CAR T-cell Therapy for Patients with Multiple Myeloma
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
The Scars You Can’t See Are the Hardest to Heal: Coping with the Impact of Graft versus Host Disease
Learn how Acceptance and Commitment Therapy can improve mental well-being.
The Scars You Can’t See Are the Hardest to Heal: Coping with the Impact of Graft versus Host Disease
Learn how Acceptance and Commitment Therapy can improve mental well-being.
Treatment Options for Sickle Cell Disease
Bone marrow transplants and gene therapy for sickle cell disease: treatment options to consider.
Live Your Best Life: How to Manage Fatigue and Adapt Routines to Maximize Quality of Life with GVHD
Learn how occupational therapists can help you improve your quality of life.
Live Your Best Life: How to Manage Fatigue and Adapt Routines to Maximize Quality of Life with GVHD
Learn how occupational therapists can help you improve your quality of life.
COVID 19 – Actualización de Invierno: Lo que Necesitan Saber los Pacientes de Trasplante
Los casos de COVID-19 están en aumento. Infórmese sobre su riesgo y las opciones de tratamiento.
COVID 19 Winter Update: What Transplant Recipients Need to Know
With cases of COVID-19 on the rise this winter, it's important to have the latest facts about your risk for getting a severe case of COVID-19.
COVID 19 Winter Update: What Transplant Recipients Need to Know
With cases of COVID-19 on the rise this winter, it's important to have the latest facts about your risk for getting a severe case of COVID-19.
GVHD Caregivers: Building Resilience for the Road to Recovery
Learn challenges and coping strategies for caregivers of patients with graft-versus-host disease.
GVHD Caregivers: Building Resilience for the Road to Recovery
Learn challenges and coping strategies for caregivers of patients with graft-versus-host disease.
Coronavirus: What Transplant Recipients Need to Know
Learn which transplant recipients are at risk for developing a severe case of COVID-19 and how to protect yourself.
Managing Ocular Graft-versus-Host Disease
Graft-versus-host disease often affects the eyes causing dryness, blurry vision and/or pain. Learn the best ways to manage ocular GVHD.
Managing Neuropathy after Transplant
Peripheral neuropathy is common after transplant. Learn the symptoms and effective treatment options.
Options for Building a Family
Strategies to consider before and after transplant, for survivors who wish to build a family.
CAR-T y Otras Inmunoterapias: Su Papel Después del Trasplante
¿Qué es la terapia con el receptor de antígeno quimérico (CAR-T)? ¿Quién es candidato para la terapia CAR-T?
CAR T and Other Immunotherapies
Learn how CAR T therapy works to fight cancer, who is a candidate for CAR T therapy, the side effects and whether it can cure or prolong life.
Treatment Options for Lymphoma Patients: When to Consider Transplant or CAR-T
If you have been diagnosed with lymphoma, is a stem cell transplant or CAR-T therapy right for you?
Treatment Options for Multiple Myeloma: What’s Possible Now? What’s in the Pipeline?
Learn about different types of myeloma, current treatment options and new, emerging therapies
Acute Myelogenous Leukemia (AML): Current Treatment Options and Promising Research
Learn about the different types of AML, current treatment options and promising therapies on the horizon.
What You Need to Know about Chronic GVHD: Current Treatment Options and Promising Research
Promising clinical trials, scientific tools and drug interventions are here now, paving the way for FDA approved treatments for GVHD.
Clinical Trials: What They Are and Who Should Participate
Clinical trials test whether new drugs or therapies can improve outcomes for patients. Learn how trials are conducted, questions to ask your medical team about a trial, and your rights if you choose to enroll in a clinical trial.
CAR-T: A New Twist on Transplants for Cancer Patients
Learn how our own immune system cells can be engineered to fight some cancers.
Transplant Options for Patients with Hodgkin Disease
Understanding current and new treatment options
Donating Bone Marrow or Stem Cells to a Relative
A comprehensive explanation of what is involved in donating bone marrow or stem cells to a relative who needs a transplant.
Stem Cell Transplants for Acute Myeloid Leukemia: What You Need to Know
A comprehensive discussion of who should consider a transplant for acute myeloid leukemia (AML) and when.
Alternative Donor Transplants: Exploring Cord Blood and Haploidentical Transplant Options
Cord blood and haploidentical (half-matched) transplants are used to treat an increasing number of patients.
Alternative Donor Transplants: Exploring Cord Blood and Haploidentical Transplant Options
Cord blood and haploidentical (half-matched) transplants are used to treat an increasing number of patients.
Family Caregivers 101: What to Expect When Caring for a Recovering Transplant Patient
An in-depth discussion about the family caregiver's role during and after transplant.
Transplants 101: An Introduction to Bone Marrow, Stem Cell and Cord Blood Transplants
An overview of bone marrow, peripheral blood stem cell and cord blood transplantation.
An Introduction to Chronic Graft-versus-Host-Disease (cGVHD)
Chronic GVHD is a common problem after a transplant using donor cells (allogeneic transplant).
Bone Marrow Transplant and Integrative Oncology
An overview of various complementary medical practices used by transplant patients, their safety and effectiveness.
